{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:57:52Z","timestamp":1779937072935,"version":"3.53.1"},"reference-count":24,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Objectives: to analyze the results of molecular methods applying for the diagnosis of mucormycosis in hematologic patients based on a literature review. Data sources: A systematic search in databases PubMed, Google Scholar for August 2019. Review eligibility criteria: original articles published in English, studies of molecular methods for the diagnosis of mucormycosis in hematologic patients. Results. We analyzed the research data from 116 hematological patients with mucormycosis, including children (6%). Patients with localized forms of mucormycosis prevailed (72%), and lung involvement was diagnosed in 58% of these cases. For molecular verification of the causative agent of mucormycosis, blood serum was most often used, less commonly postoperative and autopsy material, biopsy specimens, formalin-fixed paraffin-embedded samples and bronchoalveolar lavage, pleural fluid and sputum. The sensitivity of molecular diagnostics of mucormycosis in a cohort of hematological patients was 88.2%. Conclusion. The use of molecular techniques along with standard mycological methods will improve the diagnostics of mucormycosis in hematologic patients. However, prospective studies of the effectiveness of molecular methods for the diagnosis of mucormycosis of various etiologies in hematological patients, including children, using bronchoalveolar lavage (BAL) and cerebrospinal fluid (CSF) are needed.<\/jats:p>","DOI":"10.3390\/jof5040112","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T10:58:21Z","timestamp":1575025101000},"page":"112","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Molecular Diagnostics of Mucormycosis in Hematological Patients: A Literature Review"],"prefix":"10.3390","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3272-5263","authenticated-orcid":false,"given":"Olga V.","family":"Shadrivova","sequence":"first","affiliation":[{"name":"Department of Clinical Mycology, Allergy and Immunology, I. Mechnikov North Western State Medical University, Saint Petersburg 194291, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9307-4927","authenticated-orcid":false,"given":"Ekaterina V.","family":"Burygina","sequence":"additional","affiliation":[{"name":"Department of Clinical Mycology, Allergy and Immunology, I. Mechnikov North Western State Medical University, Saint Petersburg 194291, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6095-7531","authenticated-orcid":false,"given":"Nikolai N.","family":"Klimko","sequence":"additional","affiliation":[{"name":"Department of Clinical Mycology, Allergy and Immunology, I. Mechnikov North Western State Medical University, Saint Petersburg 194291, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kontoyiannis, D.P., Yang, H., Song, J., Kelkar, S.S., Yang, X., Azie, N., Harrington, R., Fan, A., Lee, E., and Spalding, J.R. (2016). Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: A retrospective study. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-2023-z"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"490.e1","DOI":"10.1016\/j.cmi.2014.12.021","article-title":"Invasive infections due to filamentous fungi other than Aspergillus: Epidemiology and determinants of mortality","volume":"21","author":"Slavin","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing Incidence of zygomycosis (mucormycosis), France, 1997\u20132006","volume":"15","author":"Bitar","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: The RetroZygo Study (2005\u20132007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3201\/eid1710.110087","article-title":"Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001\u20132006","volume":"17","author":"Park","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1093\/mmy\/myy116","article-title":"Contrasts between mucormycosis and aspergillosis in oncohematological patients","volume":"57","author":"Klimko","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: A 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Millon, L., Scherer, E., Rocchi, S., and Bellanger, A.P. (2019). Molecular Strategies to Diagnose Mucormycosis. J. Fungi, 5.","DOI":"10.3390\/jof5010024"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1093\/cid\/cit094","article-title":"Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients","volume":"56","author":"Millon","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"810.e1","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: Retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)","volume":"22","author":"Millon","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1099\/jmm.0.000375","article-title":"Clinical evaluation of a mucorales-specific real-time PCR assay in tissue and serum samples","volume":"65","author":"Springer","year":"2016","journal-title":"J. Med. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e00289-18","DOI":"10.1128\/JCM.00289-18","article-title":"Quantitative PCR (QPCR) detection of mucorales DNA in bronchoalveolar lavage fluid to diagnose pulmonary mucormycosis","volume":"56","author":"Scherer","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/JCM.00256-11","article-title":"Molecular methods to improve diagnosis and identification of mucormycosis","volume":"49","author":"Hammond","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/myc.12837","article-title":"Identification of Mucorales in patients with proven invasive mucormycosis by polymerase chain reaction in tissue samples","volume":"61","author":"Shokohi","year":"2018","journal-title":"Mycoses"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Guinea, J., Escribano, P., Vena, A., Mu\u00f1oz, P., Mart\u00ednez-Jim\u00e9nez, M.D.C., Padilla, B., and Bouza, E. (2017). Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179136"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.17650\/1818-8346-2017-12-2-14-22","article-title":"Mucormycosis in oncohematlogy patients (results of the prospective study)","volume":"12","author":"Klimko","year":"2017","journal-title":"Oncohematology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chikley, A., Ronen Ben-Ami, R., and Kontoyiannis, D. (2019). Mucormycosis of the Central Nervous System. J. Fungi, 5.","DOI":"10.3390\/jof5030059"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/mmy\/myx091","article-title":"Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips","volume":"56","author":"Barnes","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Patterson, T.F., and Donnelly, J.P. (2019). New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies. J. Fungi, 5.","DOI":"10.3390\/jof5010009"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/5\/4\/112\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:38:37Z","timestamp":1760189917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/5\/4\/112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["jof5040112"],"URL":"https:\/\/doi.org\/10.3390\/jof5040112","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]}}}